Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
Recruiting · NCT07247227 · Registry updated 2025-11-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC | non-small cell lung carcinoma | Recruiting | Not applicable | 2025-11-25 | NCT07247227 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking Union Medical College | 33 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| cancer hospital， Chinese Academy of medical sciences and Peking union medical college | Beijing | China | 1 |